Content area

|
|

Administrative procedurer ved godkendelse af nye lægemidler

Forfatter(e)
Mark A. Ainsworth1 ,2 & Sinan B. Sarac1
1) Medicinsk Evaluering og Biostatistik, Lægemiddelstyrelsen 2) Afdeling for Medicinske Mavetarmsygdomme, Odense Universitetshospital

Ugeskr Læger 2019;181:V10180677

Reference: 
Ugeskr Læger 2019;181: V10180677
Blad nummer: 

Mark A. Ainsworth & Sinan B. Sarac:

Approval of new medicinal products – administrative procedures

Ugeskr Læger 2019;181: V10180677

In this review, we discuss the approval of new medicinal products in Europe, which in particular for products with a new active substance is increasingly being approved through formalised collaboration between the member states of the European Union. The collaboration has resulted in a strengthening and harmonisation of the administrative procedures leading to approval of new medicinal products.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Bjørn Erik Ejbye Sørensen | 26/05
2 kommentarer
af Morten Blomgren | 24/05
2 kommentarer
af Julius Vindbjerg Nissen | 20/05
1 Kommentar
af Hans Henrik Freudenthal | 20/05
1 Kommentar